Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves

scientific article published on 24 February 2018

Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EURHEARTJ/EHY056
P932PMC publication ID5950928
P698PubMed publication ID29529259

P50authorGereon Rudolf FinkQ1511131
Matthias EndresQ15441092
Jochen A SembillQ52807949
Stephan AchenbachQ63168606
Heinz ReichmannQ64855914
Albert C. LudolphQ67390363
Peter KraftQ88740867
Sarah ZweynertQ92621641
P2093author name stringStefan Schwab
Otto W Witte
Arnd Dörfler
Peter D Schellinger
Christian Dohmen
Jens Minnerup
Peter Vajkoczy
Jens Volkmann
Karl Georg Haeusler
Jan Sobesky
Joachim Röther
Peter A Ringleb
Albrecht Günther
Markus Horn
Hansjörg Bäzner
Jan Purrucker
Timolaos Rizos
Michael Schwarz
Armin Grau
Hagen B Huttner
Frederick Palm
Frank Erbguth
Ulrich J Knappe
Hannes Lücking
Joji B Kuramatsu
Stefan T Gerner
Florian Rakers
Dominik Michalski
Gerhard F Hamann
Gernot Reimann
Hauke Schneider
Christian Urbanek
Johannes C Wöhrle
Henning Stetefeld
Sebastian Stösser
Wolfgang Müllges
Georg Hagemann
Anna Lena Fisse
Anna-Lena Schubert
Dirk Bahner
Fahid Alshammari
Henning Schwert
Hermann Neugebauer
Johannes Schurig
Jörg Glahn
Joseph Claßen
Manuel Hagen
Martin Nueckel
Maximilian I Sprügel
Miriam Bauer
Peter Michels
Sebastian S Roeder
Sigrid Wöpking
P2860cites workAnticoagulants for acute ischaemic strokeQ24187310
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationQ28262545
Management of intracranial bleeding associated with anticoagulation: balancing the risk of further bleeding against thromboembolism from prosthetic heart valvesQ28344567
Timing of vitamin K antagonist re-initiation following intracranial hemorrhage in mechanical heart valves: Systematic review and meta-analysisQ30249270
Intracerebral haemorrhageQ33442365
Oral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complicationsQ33651497
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolismQ34436061
Achieved anticoagulation vs prosthesis selection for mitral mechanical valve replacement: a population-based outcome study.Q37463870
Antithrombotic management of patients with prosthetic heart valves: current evidence and future trendsQ37580473
When should you restart anticoagulation in patients who suffer an intracranial bleed who also have a prosthetic valve?Q38071489
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesQ38192882
The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertaintiesQ38247892
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.Q38415781
Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysisQ38547884
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillationQ38671522
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.Q38771217
Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational studyQ38885515
Timing of anticoagulant re-initiation following intracerebral hemorrhage in mechanical heart valves: Survey of neurosurgeons and thrombosis expertsQ39012247
Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial FibrillationQ39080467
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesQ39180708
Mechanical versus bioprosthetic aortic valve replacementQ39263473
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trialQ39683385
Severity assessment in maximally treated ICH patients: The max-ICH scoreQ40134227
Guidelines on the management of valvular heart disease (version 2012).Q40276570
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis.Q40478828
Warfarin use leads to larger intracerebral hematomasQ41871107
The ICH score: a simple, reliable grading scale for intracerebral hemorrhageQ43503411
Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacementQ43730957
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhageQ45081496
Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhageQ46864838
Oral Anticoagulation and Functional Outcome after Intracerebral HemorrhageQ47291019
One-to-many propensity score matching in cohort studies.Q47789199
Early hemorrhage growth in patients with intracerebral hemorrhageQ48821770
2017 ESC/EACTS Guidelines for the management of valvular heart diseaseQ50196541
Risks of Thrombosis and Rehemorrhage During Early Management of Intracranial Hemorrhage in Patients With Mechanical Heart ValvesQ51693249
Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patientsQ51693700
The year in cardiology 2016: valvular heart disease.Q54595458
European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral HemorrhageQ57384692
Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionQ57484933
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparisonQ59651031
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative GroupQ73396117
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus documentQ95423935
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue19
P921main subjectanticoagulationQ63279445
P304page(s)1709-1723
P577publication date2018-05-01
P1433published inEuropean Heart JournalQ2286839
P1476titleManagement of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves
P478volume39

Reverse relations

cites work (P2860)
Q90588245Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage
Q90059386Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
Q57168432Impact of Recent Studies for the Treatment of Intracerebral Hemorrhage
Q64983401Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage.
Q97546855Stroke
Q91652065Warfarin Reinitiation After Intracranial Hemorrhage: A Case Series of Heart Valve Patients

Search more.